Objective: To analyze CD21 expression in diffuse large B cell lymphoma (DLBCL) and to explore its relationship with the clinicopathological characteristics and prognosis.
Methods: The clinical data from 80 DLBCL patients who were treated in First Hospital of Jilin University from June 2005 to September 2011 were retrospectively analyzed. The cases were subjected to immunohistochemical staining (SP method) for Ki-67, CD20, CD79a, CD3, CD43, CD5, cyclin D1, bcl-2, CD10, bcl-6, GCET-1, FOXP-1 and MUM-1 protein expression in the tumor tissue. Immunohistochemistry was also used to detect CD21 expression in the tumor tissue. SPSS 18.0 was used to analyze the relationship between CD21 expression and various clinical factors, and the relationship between various clinical factors including CD21 and overall survival.
Results: In the patients aged under 60 years, the incidence of CD21(+) lymphoma (64.0%, 16/25) was significantly higher than that of CD21(-) lymphoma (38.2%, 21/55). There were more CD21(+) lymphoma patients who were at clinical stages I-II (52.0%, 13/25) than patients with CD21(-)lymphomas (23.6%, 13/55). There were also more CD21(+) lymphoma patients (68.0%, 17/25) having less than two extranodal sites involvement than CD21(-)lymphoma patients (41.8%, 23/55). In addition, there were more CD21(+) lymphoma patients with IPI 0-2 (68.0%, 17/25) than CD21(-)lymphoma patients (41.8%, 23/55). There were more CD21(+) lymphoma patients with GCB subtype (60.0%, 15/25) than CD21(-)lymphoma patients (23.6%, 13/55). Death related to DLBCL was less in CD21(+) lymphoma patients (32.0%, 8/25) than CD21(-) lymphoma patients (56.4%, 31/55). Univariate analysis showed that these clinical pathological characteristics affected the overall survival of DLBCL patients, including age, ECOG score, LDH, extranodal involvement, IPI index, CD21 expression, treatment option and efficacy (P < 0.05) . Cox multivariate analysis showed that ECOG score, LDH, extranodal involvement, CD21 expression were closely related to prognosis, and the difference was statistically significant (P < 0.05). Among the 80 patients, the overall survival (OS) of CD21(+) lymphoma patients was significantly higher than that of CD21(-) lymphoma patients.
Conclusions: The expression of CD21 is associated with young age at onset, early clinical stage, small number of involvement and low IPI index. The OS and median overall survival of CD21(+) lymphoma patients are significantly higher than those of CD21(-) patients. CD21 expression, ECOG score, LDH, extranodal involvement are independent prognostic factors in DLBCL, and in particular, the expression of CD21 is more significant in the prognosis of DLBCL patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3760/cma.j.issn.0529-5807.2012.12.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary gastric T-cell lymphomas (PGTL) are exceedingly rare with an estimated incidence of 0.0091 per 100,000 person-years, affecting mainly elderly males. PGTL can present with a variety of gastrointestinal symptoms, but patients only rarely present with perforation.
View Article and Find Full Text PDFDelayed diagnosis of angioimmunoblast T-cell lymphoma presenting with immunoglobulin a vasculitis.
Ren Fail
December 2024
Department of Nephrology, Affiliated Hospital of Jining Medical College, Jining, China.
Although vasculitis and renal involvement might be associated with malignancy, they are rarely associated with lymphoproliferative diseases. We observed a case of immunoglobulin A vasculitis associated with segmental and focal glomerulonephritis in a patient with Angioimmunoblastic T-cell lymphoma. The most interesting aspect of this case is that this patient's main initial manifestations were skin rash and fever.
View Article and Find Full Text PDFClinicopathological and molecular genetic insights into EBV-positive inflammatory follicular dendritic cell sarcoma.
Hum Pathol
November 2024
Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, 350001, Fujian, China. Electronic address:
Article Synopsis
- - This study focused on analyzing 12 cases of Epstein-Barr virus (EBV)-positive inflammatory follicular dendritic cell sarcoma (EBV + IFDCS) to understand its clinical and pathological features, which are not fully described.
- - Patients ranged in age from 21 to 84 years, with a predominance of females, and all were alive at the last follow-up despite some experiencing recurrence or metastasis; various subtypes were identified within the cases.
- - The study revealed significant differences in marker expressions between EBV + IFDCS and traditional follicular dendritic cell sarcoma (FDCS), along with unique genetic mutations and variations that were observed, contributing to a better understanding of this rare condition
Cross-talk between immune cells and tumor cells in non-Hodgkin lymphomas arising in common variable immunodeficiency.
Expert Rev Clin Immunol
December 2024
Department of Pediatrics (Allergy & Immunology Unit), Postgraduate Institute of Medical Education and Research, PGIMER, Chandigarh, India.
Article Synopsis
- Common Variable Immune Deficiency (CVID) is the most common primary immune deficiency in adults and is linked to higher rates of Non-Hodgkin Lymphomas (NHLs).
- The review discusses changes in immune cells, genetic factors, and tissue pathology specifically related to NHLs in CVID patients.
- Immune defects in CVID, such as reduced T cell types and alterations in B cells, along with genetic markers and signaling pathways, may contribute to increased lymphoma risk and require further research to identify potential prognostic indicators.
Clinicopathological diagnosis of Lennert lymphoma: a case report and review of the literature.
Diagn Pathol
August 2024
Department of Pathology, Shenzhen Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Article Synopsis
- Lennert lymphoma (LL) is a rare type of peripheral T-cell lymphoma that is often misdiagnosed due to unclear diagnostic criteria; careful examination of cytomorphology and immunohistochemistry is crucial for accurate diagnosis.
- A case study highlights a patient diagnosed with LL through these methods, showing small to medium-sized CD4(+) T cells and no indicators of other T cell types, with notable histiocytes and EBV(+) cells present.
- The patient achieved complete remission after chemotherapy and remained disease-free for five years, indicating that accurate diagnosis and treatment can lead to positive outcomes in LL cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!